Latest news

Filters
July 1, 2021

6e Challenge Qualité de vie du patient : cinq finalistes reçoivent 5000 francs chacun et avancent en finale

Read more
June 16, 2021

Debiopharm and Ubix Therapeutics launch research to develop a new anti-cancer modality – antibody degraducer® conjugates

Read more
June 14, 2021

Debiopharm’s CD37 antibody drug conjugate shows promising phase II results for the treatment of B-cell malignancies

Read more
April 20, 2021

Debiopharm Collaborates With Innocentive For The Launch of A Global Challenge To Develop A Single-Dose mRNA Covid-19 Vaccine

Read more
March 31, 2021

Debiopharm Launches the “IDEAL” Initiative to Strengthen the Lemanic Region as a Hub for Life Science Innvovation

Read more
March 1, 2021

Debiopharm Grants a Worldwide Exclusive License to Merck for the Development and Commercialization of Xevinapant

Read more
February 25, 2021

Debiopharm and Genome & Company Join Forces to Create New Highly Specific Therapies For Cancer Patients

Read more
February 15, 2021

Le Challenge 2020 pour la qualité de vie du patient récompense le projet Oculus de sonnette connectée actionnée par le…

Read more
January 18, 2021

Phase II Research Against Covid-19 Launched in France with Debiopharm’s Antiviral Alisporivir

Read more

Stay informed

Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.